NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Niki BioSolutions, Inc.
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$2.08+0.05 (+2.46%)
Close on Oct 19, 2026
- Market cap
- $16.66M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Niki BioSolutions has not reported a dividend
No dividend per share appears in Niki BioSolutions's annual filings since fiscal 2017.